Key result
Valvular intervention prior to non-cardiac surgery is recommended for symptomatic patients or those meeting standard criteria, based primarily on consensus opinion and observational registries.
Why the study?
Recommended perioperative risk scores prioritise surgical procedure risk and cardiovascular risk factors while neglecting the presence or extent of VHD, and randomised trials investigating therapeutic approaches of valvular intervention prior to NCS are lacking.
Perioperative management of patients with valvular heart disease undergoing non-cardiac surgery should be tailored to the specific valve lesion and discussed within a multidisciplinary heart team.
VHD may increase perioperative cardiac risk in NCS beyond current scores; leaves open need for dedicated risk models in prospective validation.
In patients with significant valvular heart disease (VHD) undergoing non-cardiac surgery (NCS), perioperative adverse cardiac events are a relevant issue. Although postoperative outcomes can be adversely affected by valve-related haemodynamic instability, recommended perioperative risk scores prioritise the risk of the surgical procedure and the presence of cardiovascular risk factors, neglecting the presence or extent of VHD. Perioperative management and anaesthetic approach should focus on the underlying type and severity of VHD, the compensatory mechanisms deployed by left ventricle and right ventricle and the type and risk of NCS. Due to the lack of randomised trials investigating different therapeutic approaches of valvular intervention prior to NCS, recommendations mainly rely on consensus opinion and inference based on large observational registries. As a general rule, valvular intervention is recommended prior to NCS in symptomatic patients or in those who meet standard criteria for cardiac intervention. In the absence of such conditions, it is reasonable to perform NCS with tailored anaesthetic management and close invasive perioperative haemodynamic monitoring. However, patient-specific management strategies should be discussed with the heart team preoperatively. Symptomatic patients with severe VHD or those undergoing high-risk NCS should ideally be treated at a high-volume medical centre that is equipped to manage haemodynamically complex patients during the perioperative period.
No takes yet. Share an insight, caveat, or question.
Sorrentino et al. (2021) conducted a review in Valvular heart disease. Perioperative management and valvular intervention was evaluated. Valvular intervention prior to non-cardiac surgery is recommended for symptomatic patients or those meeting standard criteria, based primarily on consensus opinion and observational registries.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: